Nothing Special   »   [go: up one dir, main page]

Crisp et al., 2010 - Google Patents

The effect of particle size on the dehydration/rehydration behaviour of lactose

Crisp et al., 2010

Document ID
16299760099985567710
Author
Crisp J
Dann S
Edgar M
Blatchford C
Publication year
Publication venue
International Journal of Pharmaceutics

External Links

Snippet

Ethanolic suspensions of spray dried and micronized alpha lactose monohydrate (Lα· H2O) with average particle size between 3 and 200μm, have been prepared and their dehydration behaviour was investigated by 13C CP-MASNMR spectroscopy. Sub-micron lactose …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin

Similar Documents

Publication Publication Date Title
Dhumal et al. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery
Sahakijpijarn et al. Using thin film freezing to minimize excipients in inhalable tacrolimus dry powder formulations
DE60225242T2 (en) PROCESS FOR PRODUCING NANOPARTICLES
US6475524B1 (en) Composition of matter
Carvalho et al. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats
Carr et al. Particle formation of budesonide from alcohol-modified subcritical water solutions
HU217770B (en) Process for conditioning materials or materialmixtures and this preparated pharmacologically compositions
RU2666963C2 (en) Aggregated particles
HUE027465T2 (en) Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
Ogienko et al. Large porous particles for respiratory drug delivery. Glycine-based formulations
Steele Preformulation as an aid to product design in early drug development
Kaialy et al. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol—acetone
Xu et al. Design and evaluation of novel solid self-nanodispersion delivery system for andrographolide
Ober et al. Preparation of rifampicin/lactose microparticle composites by a supercritical antisolvent-drug excipient mixing technique for inhalation delivery
Saboti et al. Novel budesonide particles for dry powder inhalation prepared using a microfluidic reactor coupled with ultrasonic spray freeze drying
UA120418C2 (en) Particle size reduction of an antimuscarinic compound
Rahmati et al. Effect of formulation ingredients on the physical characteristics of salmeterol xinafoate microparticles tailored by spray freeze drying
US7172752B2 (en) Combination particles for the treatment of asthma
Kubavat et al. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations
Crisp et al. The effect of particle size on the dehydration/rehydration behaviour of lactose
Ali et al. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote
Muralidharan et al. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
Zellnitz et al. Crystallization speed of salbutamol as a function of relative humidity and temperature
Hu et al. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation
de Castro et al. Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis